| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |